242 related articles for article (PubMed ID: 27863562)
1. Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
Sheikhbahaei S; Mena E; Pattanayak P; Taghipour M; Solnes LB; Subramaniam RM
PET Clin; 2017 Jan; 12(1):105-118. PubMed ID: 27863562
[TBL] [Abstract][Full Text] [Related]
2. Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
Subramaniam RM
PET Clin; 2017 Jan; 12(1):1-5. PubMed ID: 27863561
[TBL] [Abstract][Full Text] [Related]
3. Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.
Wright CL; Maly JJ; Zhang J; Knopp MV
PET Clin; 2017 Jan; 12(1):63-82. PubMed ID: 27863567
[TBL] [Abstract][Full Text] [Related]
4. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
Choudhury P; Gupta M
Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.
Sanli Y; Yilmaz E; Subramaniam RM
PET Clin; 2017 Oct; 12(4):423-435. PubMed ID: 28867113
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging and Precision Medicine in Head and Neck Cancer.
Mena E; Thippsandra S; Yanamadala A; Redy S; Pattanayak P; Subramaniam RM
PET Clin; 2017 Jan; 12(1):7-25. PubMed ID: 27863568
[TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers.
Zukotynski KA; Kim CK
PET Clin; 2017 Oct; 12(4):393-405. PubMed ID: 28867111
[TBL] [Abstract][Full Text] [Related]
8. Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.
Mallik AK; Drzezga A; Minoshima S
PET Clin; 2017 Jan; 12(1):119-136. PubMed ID: 27863563
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging and Precision Medicine in Prostate Cancer.
Ceci F; Fiorentino M; Castellucci P; Fanti S
PET Clin; 2017 Jan; 12(1):83-92. PubMed ID: 27863569
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging and Precision Medicine in Lung Cancer.
Zukotynski KA; Gerbaudo VH
PET Clin; 2017 Jan; 12(1):53-62. PubMed ID: 27863566
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.
Larson SM; Schwartz LH
J Nucl Med; 2006 Jun; 47(6):901-3. PubMed ID: 16741296
[No Abstract] [Full Text] [Related]
12. Molecular Imaging and Precision Medicine in Breast Cancer.
Chudgar AV; Mankoff DA
PET Clin; 2017 Jan; 12(1):39-51. PubMed ID: 27863565
[TBL] [Abstract][Full Text] [Related]
13. Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.
Basu S; Parghane RV
PET Clin; 2017 Jan; 12(1):27-37. PubMed ID: 27863564
[TBL] [Abstract][Full Text] [Related]
14. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
15. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
Basu B; Basu S
Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
[TBL] [Abstract][Full Text] [Related]
16. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of 18F-FDG PET/CT in the treatment of sarcomas].
Borbély K; Németh Z; Kásler M
Magy Onkol; 2014 Mar; 58(1):24-31. PubMed ID: 24712003
[TBL] [Abstract][Full Text] [Related]
18. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
Ziai P; Hayeri MR; Salei A; Salavati A; Houshmand S; Alavi A; Teytelboym OM
Radiographics; 2016; 36(2):481-96. PubMed ID: 26963458
[TBL] [Abstract][Full Text] [Related]
19. Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers.
Zhao B; Schwartz LH; Larson SM
J Nucl Med; 2009 Feb; 50(2):239-49. PubMed ID: 19164218
[TBL] [Abstract][Full Text] [Related]
20. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]